Association between plasma plasminogen activator inhibitor-1 and survival in colorectal cancer

BMJ

Volumn 317, Issue 7160, 1998, Pages 750-

  Sattar, Naveed ^a   Mcmillan, Donald C ^a   Nielsen, Hans J⊘rgen ^b   Christensen, Ib Jarle ^b   Brünner, Nils ^b   S⊘rensen, Steen ^b  

^a GLASGOW ROYAL INFIRMARY   (United Kingdom)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; PLASMINOGEN ACTIVATOR INHIBITOR 1;

ACUTE PHASE RESPONSE; CANCER SURVIVAL; COLON SURGERY; COLORECTAL CANCER; HUMAN; IMMUNOHISTOCHEMISTRY; LETTER; NONHUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN DETERMINATION;

C-REACTIVE PROTEIN; COLORECTAL NEOPLASMS; DISEASE PROGRESSION; HUMANS; PLASMINOGEN ACTIVATOR INHIBITOR 1; TUMOR MARKERS, BIOLOGICAL;

EID: 0032511609     PISSN: 09598138     EISSN: 14685833     Source Type: Journal    
DOI: 10.1136/bmj.317.7160.750     Document Type: Letter

References (9)

1. Nielsen HJ, Pappot H, Christensen IJ, Brünner N, Thorlacius-Ussing O, Moesgaard F, et al. Association between plasmac oncentrations of plasminogen activator inhibitor-1 and survival in patientsw ith colorectal cancer. BMJ 1998; 316: 829–830(14 March.)
2. De Mello J, Struthers L, Turner R, Cooper EH, Giles GRa nd the Yorkshire Regional Gastrointestinal Cancer Research Group. Multivariate analyses as aids to diagnosis and assessment of prognosis ing astrointestinal cancer. Br J Cancer 1983; 48: 341–348
3. McMillan DC, Wotherspoon HA, Fearon KCH, Sturgeon CM, Cooke TG, McArdle CS. A prospective study of tumour recurrence and the acutep hase response after apparently curative colorectal cancer. Am J Surg 1995; 170: 319–322
4. Falconer JS, Fearon KCH, Plester CE, Ross JA, Elton R, Wigmore SJ, et al. Acute phase protein response and survival duration ofp atients with pancreatic cancer. Cancer 1995; 75: 2077–2082
5. Haverkate F, Thompson SG, Duckert F, Michalopoulos CD, Moulopoulos S, Mandalaki T, et al. Haemostasis factors in angina pectoris;r elation to gender, age and acute-phase reaction, results of the ECAT Angina Pectoris Study Group. Thromb Hemost 1995; 73: 561–567
6. Pappot H, Gårdsvoll H, Rømer J, Pedersen AN, Grøndahl-Hansen J, Pyke C, et al. Plasminogen activator inhibitor type-1 inc ancer. Therapeutic and prognostic implications. Biol Chem Hoppe Seyler 1995; 376: 259–267
7. Pyke C, Kristensen P, Ralfkiaer E, Eriksen J, Danø K. The plasminogen activation system in human colon cancer: messenger RNA for thei nhibitor PAI-1 is located in endothelial cells in the tumor stroma. Cancer Res 1991; 51: 4067–4071
8. Bajou K, Noël A, Gerard R, Brünner N, Holst-Hansen C, Fusenig N, et al. Absence of host plasminogen activator inhibitor-1 preventsc ancer invasion. Nature Med (in press).
9. Deng G, Curriden SA, Wang SJ, Rosenberg S, Loskutoff DJ. Is plasminogen activator inhibitor-1 the molecular switch that governsu rokinase receptor-mediated cell adhesion and release? J Cell Biol 1996; 134: 1563–1571